DRUG
Price
$23.27
Change
-$1.51 (-6.09%)
Updated
Jun 27 closing price
Capitalization
173.76M
SEER
Price
$2.12
Change
+$0.06 (+2.91%)
Updated
Jun 27 closing price
Capitalization
124.75M
39 days until earnings call
Interact to see
Advertisement

DRUG vs SEER

Header iconDRUG vs SEER Comparison
Open Charts DRUG vs SEERBanner chart's image
Bright Minds Biosciences
Price$23.27
Change-$1.51 (-6.09%)
Volume$627.92K
Capitalization173.76M
Seer
Price$2.12
Change+$0.06 (+2.91%)
Volume$143.98K
Capitalization124.75M
DRUG vs SEER Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. SEER commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a Hold and SEER is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (DRUG: $23.27 vs. SEER: $2.12)
Brand notoriety: DRUG and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 1578% vs. SEER: 46%
Market capitalization -- DRUG: $173.76M vs. SEER: $124.75M
DRUG [@Biotechnology] is valued at $173.76M. SEER’s [@Biotechnology] market capitalization is $124.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, both DRUG and SEER are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 4 TA indicator(s) are bullish while SEER’s TA Score has 3 bullish TA indicator(s).

  • DRUG’s TA Score: 4 bullish, 4 bearish.
  • SEER’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DRUG is a better buy in the short-term than SEER.

Price Growth

DRUG (@Biotechnology) experienced а -16.39% price change this week, while SEER (@Biotechnology) price change was +5.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

SEER is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRUG($174M) has a higher market cap than SEER($125M). SEER YTD gains are higher at: -8.225 vs. DRUG (-35.397). DRUG has higher annual earnings (EBITDA): -2.67M vs. SEER (-89.36M). SEER has more cash in the bank: 240M vs. DRUG (57.9M). DRUG has less debt than SEER: DRUG (183K) vs SEER (25.4M). SEER has higher revenues than DRUG: SEER (15.1M) vs DRUG (0).
DRUGSEERDRUG / SEER
Capitalization174M125M139%
EBITDA-2.67M-89.36M3%
Gain YTD-35.397-8.225430%
P/E RatioN/AN/A-
Revenue015.1M-
Total Cash57.9M240M24%
Total Debt183K25.4M1%
TECHNICAL ANALYSIS
Technical Analysis
DRUGSEER
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRPT0.06N/A
N/A
MacReport.Net, Inc. (The)
SEOVF0.12N/A
N/A
SERNOVA BIOTHERAPEUTICS INC.
TTUUF6.77N/A
N/A
Tokyu Fudosan Holdings Corp
PLRRF5.98N/A
N/A
Polar Capital Holdings PLC
CRHKY6.33-0.06
-0.94%
China Resources Beer Holdings Company Limited

DRUG and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRUG has been loosely correlated with PHMMF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DRUG jumps, then PHMMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRUG
1D Price
Change %
DRUG100%
-6.09%
PHMMF - DRUG
44%
Loosely correlated
N/A
TVGN - DRUG
30%
Poorly correlated
+5.08%
ATYR - DRUG
30%
Poorly correlated
-1.57%
SEER - DRUG
29%
Poorly correlated
+2.91%
PHGUF - DRUG
28%
Poorly correlated
N/A
More

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with RGNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
+2.91%
RGNX - SEER
40%
Loosely correlated
-4.11%
PALI - SEER
38%
Loosely correlated
-1.93%
DNLI - SEER
38%
Loosely correlated
-2.69%
NUVB - SEER
36%
Loosely correlated
-2.54%
TRDA - SEER
35%
Loosely correlated
-1.57%
More